|
|
||||||||
Vol. 54, Issue 2, 203-218, June 2002
Endocrine, Mucosal Inflammation, Smooth Muscle and Cancer Biology
Research Groups, Department of Pharmacology and Therapeutics and
Department of Medicine, University of Calgary, Faculty of Medicine,
Calgary, Alberta, Canada
I. Introduction
II. Nomenclature and Use of the Proteinase-Activated Receptor
Designation
III. Receptor Subtypes
A. Defining Proteinase-Activated Receptor Subtypes Using Enzyme and
Peptide Agonists
B. Receptor Antagonists and Receptor Subtypes
C. Molecular Definition of Receptor Subtypes
IV. Molecular Aspects of Proteinase-Activated Receptor Activation
A. The Tethered Ligand Mechanism
B. Structure-Activity Relationships for Receptor Activation by the
Tethered Ligand Sequences
C. Receptor Domains Involved in Ligand Activation
D. Signaling, Desensitization, and Receptor Internalization
E. Receptor Activation and Proteinase Susceptibility: What Are the
Endogenous Proteinase-Activated Receptor Regulators?
V. Physiological Roles of Proteinase-Activated Receptors
A. Thrombin Targets: Proteinase-Activated Receptors 1, 3, and 4
B. Proteinase-Activated Receptor 2, a Trypsin Target
VI. Future Issues and Conclusions
Acknowledgments
References
Proteinase-activated receptors (PARs) represent a unique subclass of G-protein-coupled receptors of which four family members have now been cloned from a number of species. The novel mechanism of receptor activation involves the proteolytic unmasking of a cryptic N-terminal receptor sequence that, remaining tethered, binds to and triggers receptor function. In addition, short (five to six amino acids) synthetic peptides, based on the proteolytically revealed motif, can activate PARs without the unmasking of the tethered ligand. This article summarizes the experiments leading to the pharmacological characterization and cloning of the four PAR family members and provides a rationale for their designation by the acronym "PAR". The ability to distinguish among the PARs pharmacologically 1) with selective proteinase activators, 2) with receptor-selective peptide agonists, and 3) with peptide and nonpeptide antagonists is discussed, as are the molecular mechanisms of receptor activation and desensitization/internalization. Finally, the potential physiological roles of the PARs, which are widely distributed in many organs in the settings of tissue injury, repair, and remodeling, including embryogenesis and oncogenesis are discussed, and the newly appreciated roles of proteinases as signaling molecules that can act as either functional agonists or antagonists are highlighted.
This article has been cited by other articles:
![]() |
M. Bruysters, M. Verhoef-Post, and A. P. N. Themmen Asp330 and Tyr331 in the C-terminal Cysteine-rich Region of the Luteinizing Hormone Receptor Are Key Residues in Hormone-induced Receptor Activation J. Biol. Chem., September 19, 2008; 283(38): 25821 - 25828. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rallabhandi, Q. M. Nhu, V. Y. Toshchakov, W. Piao, A. E. Medvedev, M. D. Hollenberg, A. Fasano, and S. N. Vogel Analysis of Proteinase-activated Receptor 2 and TLR4 Signal Transduction: A NOVEL PARADIGM FOR RECEPTOR COOPERATIVITY J. Biol. Chem., September 5, 2008; 283(36): 24314 - 24325. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hollenberg, B. Renaux, E. Hyun, S. Houle, N. Vergnolle, M. Saifeddine, and R. Ramachandran Derivatized 2-Furoyl-LIGRLO-amide, a Versatile and Selective Probe for Proteinase-Activated Receptor 2: Binding and Visualization J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Lang, I. J. Guthmundsdottir, N. A. Boon, C. A. Ludlam, K. A. Fox, and D. E. Newby Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers smoking, thrombin, and vascular responses in vivo. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 33 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Shpacovitch, M. Feld, M. D. Hollenberg, T. A. Luger, and M. Steinhoff Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity J. Leukoc. Biol., June 1, 2008; 83(6): 1309 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Guthmundsdottir, N. N. Lang, N. A. Boon, C. A. Ludlam, D. J. Webb, K. A. Fox, and D. E. Newby Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans. J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1749 - 1756. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. van der Merwe, M. D. Hollenberg, and W. K. MacNaughton EGF receptor transactivation and MAP kinase mediate proteinase-activated receptor-2-induced chloride secretion in intestinal epithelial cells Am J Physiol Gastrointest Liver Physiol, February 1, 2008; 294(2): G441 - G451. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saifeddine, M. L. Seymour, Y.-P. Xiao, S. J. Compton, S. Houle, R. Ramachandran, W. K. MacNaughton, S. Simonet, C. Vayssettes-Courchay, T. J. Verbeuren, et al. Proteinase-activated receptor-2 activating peptides: distinct canine coronary artery receptor systems Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3279 - H3289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Slofstra, M. F. Bijlsma, A. P. Groot, P. H. Reitsma, T. Lindhout, H. ten Cate, and C. A. Spek Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation Blood, November 1, 2007; 110(9): 3176 - 3182. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bengrine, J. Li, L. L. Hamm, and M. S. Awayda Indirect Activation of the Epithelial Na+ Channel by Trypsin J. Biol. Chem., September 14, 2007; 282(37): 26884 - 26896. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirano, N. Nomoto, M. Hirano, F. Momota, A. Hanada, and H. Kanaide Distinct Ca2+ Requirement for NO Production between Proteinase-Activated Receptor 1 and 4 (PAR1 and PAR4) in Vascular Endothelial Cells J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 668 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ayoub, D. Maurel, V. Binet, M. Fink, L. Prezeau, H. Ansanay, and J.-P. Pin Real-Time Analysis of Agonist-Induced Activation of Protease-Activated Receptor 1/G{alpha}i1 Protein Complex Measured by Bioluminescence Resonance Energy Transfer in Living Cells Mol. Pharmacol., May 1, 2007; 71(5): 1329 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Huang, L. Dong, T. Kozasa, and G. C. Le Breton Signaling through G{alpha}13 Switch Region I Is Essential for Protease-activated Receptor 1-mediated Human Platelet Shape Change, Aggregation, and Secretion J. Biol. Chem., April 6, 2007; 282(14): 10210 - 10222. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujiyoshi, K. Hirano, M. Hirano, J. Nishimura, S. Takahashi, and H. Kanaide Plasmin Induces Endothelium-Dependent Nitric Oxide-Mediated Relaxation in the Porcine Coronary Artery Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 949 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ramachandran, L. R. Sadofsky, Y. Xiao, A. Botham, M. Cowen, A. H. Morice, and S. J Compton Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4 Am J Physiol Lung Cell Mol Physiol, March 1, 2007; 292(3): L788 - L798. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bretschneider, B. Uzonyi, A.-A. Weber, J. W. Fischer, R. Pape, K. Lotzer, and K. Schror Human Vascular Smooth Muscle Cells Express Functionally Active Endothelial Cell Protein C Receptor Circ. Res., February 2, 2007; 100(2): 255 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinagawa, J. A. Martin, V. A. Ploplis, and F. J. Castellino Coagulation Factor Xa Modulates Airway Remodeling in a Murine Model of Asthma Am. J. Respir. Crit. Care Med., January 15, 2007; 175(2): 136 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kida, H. Inoue, T. Shimizu, and K. Kuwano Serratia marcescens Serralysin Induces Inflammatory Responses through Protease-Activated Receptor 2 Infect. Immun., January 1, 2007; 75(1): 164 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirano The Roles of Proteinase-Activated Receptors in the Vascular Physiology and Pathophysiology Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 27 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fukunaga, K. Hirano, M. Hirano, N. Niiro, J. Nishimura, Y. Maehara, and H. Kanaide Upregulation of proteinase-activated receptors and hypercontractile responses precede development of arterial lesions after balloon injury Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2388 - H2395. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Oikonomopoulou, K. K. Hansen, M. Saifeddine, I. Tea, M. Blaber, S. I. Blaber, I. Scarisbrick, P. Andrade-Gordon, G. S. Cottrell, N. W. Bunnett, et al. Proteinase-activated Receptors, Targets for Kallikrein Signaling J. Biol. Chem., October 27, 2006; 281(43): 32095 - 32112. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Gudmundsdottir, I. L. Megson, J. S. Kell, C. A. Ludlam, K. A.A. Fox, D. J. Webb, and D. E. Newby Direct Vascular Effects of Protease-Activated Receptor Type 1 Agonism In Vivo in Humans Circulation, October 10, 2006; 114(15): 1625 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev, October 1, 2006; 86(4): 1309 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beinborn Class B GPCRs: A Hidden Agonist Within? Mol. Pharmacol., July 1, 2006; 70(1): 1 - 4. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Trepat, F. Puig, N. Gavara, J. J. Fredberg, R. Farre, and D. Navajas Effect of stretch on structural integrity and micromechanics of human alveolar epithelial cell monolayers exposed to thrombin Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1104 - L1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chignard and D. Pidard Neutrophil and Pathogen Proteinases versus Proteinase-Activated Receptor-2 Lung Epithelial Cells: More Terminators than Activators. Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 394 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takekawa, C. Ina, R. Sato, K. Toma, and H. Ogawa Novel Carbohydrate-binding Activity of Pancreatic Trypsins to N-Linked Glycans of Glycoproteins J. Biol. Chem., March 31, 2006; 281(13): 8528 - 8538. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Luo, Y. Wang, T. Hanck, R. Stricker, and G. Reiser Jab1, a Novel Protease-activated Receptor-2 (PAR-2)-interacting Protein, Is Involved in PAR-2-induced Activation of Activator Protein-1 J. Biol. Chem., March 24, 2006; 281(12): 7927 - 7936. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Adam, K. K. Hansen, O. F. Astudillo, L. Coulon, F. Bex, X. Duhant, E. Jaumotte, M. D. Hollenberg, and A. Jacquet The House Dust Mite Allergen Der p 1, Unlike Der p 3, Stimulates the Expression of Interleukin-8 in Human Airway Epithelial Cells via a Proteinase-activated Receptor-2-independent Mechanism J. Biol. Chem., March 17, 2006; 281(11): 6910 - 6923. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Kelso, J. C. Lockhart, T. Hembrough, L. Dunning, R. Plevin, M. D. Hollenberg, C. P. Sommerhoff, J. S. McLean, and W. R. Ferrell Therapeutic Promise of Proteinase-Activated Receptor-2 Antagonism in Joint Inflammation J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1017 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Noorbakhsh, S. Tsutsui, N. Vergnolle, L. A. Boven, N. Shariat, M. Vodjgani, K. G. Warren, P. Andrade-Gordon, M. D. Hollenberg, and C. Power Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis J. Exp. Med., February 21, 2006; 203(2): 425 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Cheema, C. E. Ward, and S. K. Fisher Subnanomolar Concentrations of Thrombin Enhance the Volume-Sensitive Efflux of Taurine from Human 1321N1 Astrocytoma Cells J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 755 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kawao, M. Nagataki, K. Nagasawa, S. Kubo, K. Cushing, T. Wada, F. Sekiguchi, S. Ichida, M. D. Hollenberg, W. K. MacNaughton, et al. Signal Transduction for Proteinase-Activated Receptor-2-Triggered Prostaglandin E2 Formation in Human Lung Epithelial Cells J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 576 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Roviezzo, M. Bucci, V. Brancaleone, A. Di Lorenzo, P. Geppetti, S. Farneti, L. Parente, G. Lungarella, S. Fiorucci, and G. Cirino Proteinase-Activated Receptor-2 Mediates Arterial Vasodilation in Diabetes Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2349 - 2354. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Wettschureck and S. Offermanns Mammalian G Proteins and Their Cell Type Specific Functions Physiol Rev, October 1, 2005; 85(4): 1159 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Johansson, C. Lawson, M. Dabare, D. Syndercombe-Court, A. C. Newland, G. L. Howells, and M. G. Macey Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1{beta} J. Leukoc. Biol., October 1, 2005; 78(4): 967 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sharma, X. Tao, A. Gopal, B. Ligon, M. L. Steer, and G. Perides Calcium dependence of proteinase-activated receptor 2 and cholecystokinin- mediated amylase secretion from pancreatic acini Am J Physiol Gastrointest Liver Physiol, October 1, 2005; 289(4): G686 - G695. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Laurent No Bit PARt for PAR-1 Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 213 - 215. [Full Text] [PDF] |
||||
![]() |
T. Suzuki, T. J. Moraes, E. Vachon, H. H. Ginzberg, T.-T. Huang, M. A. Matthay, M. D. Hollenberg, J. Marshall, C. A. G. McCulloch, M. T. H. Abreu, et al. Proteinase-Activated Receptor-1 Mediates Elastase-Induced Apoptosis of Human Lung Epithelial Cells Am. J. Respir. Cell Mol. Biol., September 1, 2005; 33(3): 231 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yufu, K. Hirano, D. Bi, M. Hirano, J. Nishimura, Y. Iwamoto, and H. Kanaide Rac1 Regulation of Surface Expression of Protease-Activated Receptor-1 and Responsiveness to Thrombin in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1506 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. McLaughlin, M. R. Mazzoni, J. H. Cleator, L. Earls, A. L. Perdigoto, J. D. Brooks, J. A. S. Muldowney III, D. E. Vaughan, and H. E. Hamm Thrombin Modulates the Expression of a Set of Genes Including Thrombospondin-1 in Human Microvascular Endothelial Cells J. Biol. Chem., June 10, 2005; 280(23): 22172 - 22180. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Hansen, P. M. Sherman, L. Cellars, P. Andrade-Gordon, Z. Pan, A. Baruch, J. L. Wallace, M. D. Hollenberg, and N. Vergnolle A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis PNAS, June 7, 2005; 102(23): 8363 - 8368. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Noorbakhsh, N. Vergnolle, J. C. McArthur, C. Silva, M. Vodjgani, P. Andrade-Gordon, M. D. Hollenberg, and C. Power Proteinase-Activated Receptor-2 Induction by Neuroinflammation Prevents Neuronal Death during HIV Infection J. Immunol., June 1, 2005; 174(11): 7320 - 7329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dulon, D. Leduc, G. S. Cottrell, J. D'Alayer, K. K. Hansen, N. W. Bunnett, M. D. Hollenberg, D. Pidard, and M. Chignard Pseudomonas aeruginosa Elastase Disables Proteinase-Activated Receptor 2 in Respiratory Epithelial Cells Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 411 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tang, B. Low, S. A. Rutherford, and Q. Hao Thrombin induces endocytosis of endoglin and type-II TGF-{beta} receptor and down-regulation of TGF-{beta} signaling in endothelial cells Blood, March 1, 2005; 105(5): 1977 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response Endocr. Rev., February 1, 2005; 26(1): 1 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Buresi, N. Vergnolle, K. A. Sharkey, C. M. Keenan, P. Andrade-Gordon, G. Cirino, D. Cirillo, M. D. Hollenberg, and W. K. MacNaughton Activation of proteinase-activated receptor-1 inhibits neurally evoked chloride secretion in the mouse colon in vitro Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G337 - G345. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sharma, X. Tao, A. Gopal, B. Ligon, P. Andrade-Gordon, M. L. Steer, and G. Perides Protection against acute pancreatitis by activation of protease-activated receptor-2 Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G388 - G395. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ma, R. Perini, W. McKnight, M. Dicay, A. Klein, M. D. Hollenberg, and J. L. Wallace Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets PNAS, January 4, 2005; 102(1): 216 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishikawa, K. Kawai, M. Tanaka, H. Ohtani, S. Tanaka, C. Kitagawa, M. Nishida, T. Abe, H. Araki, and A. Kawabata Protease-Activated Receptor-2 (PAR-2)-Related Peptides Induce Tear Secretion in Rats: Involvement of PAR-2 and Non-PAR-2 Mechanisms J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 324 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, M. D. Hollenberg, and R. Loutzenhiser Redundant signaling mechanisms contribute to the vasodilatory response of the afferent arteriole to proteinase-activated receptor-2 Am J Physiol Renal Physiol, January 1, 2005; 288(1): F65 - F75. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Tanaka, T. Morita, A. Nezu, A. Tanimura, I. Mizoguchi, and Y. Tojyo Signaling Mechanisms Involved in Protease-Activated Receptor-1-Mediated Interleukin-6 Production by Human Gingival Fibroblasts J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 778 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schaffner, C. C. King, D. Schaer, and D. G. Guiney Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes J. Leukoc. Biol., November 1, 2004; 76(5): 1010 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K Chan, N. Vergnolle, M. D Hollenberg, and P.-Y. von der Weid Proteinase-activated receptor 2 activation modulates guinea-pig mesenteric lymphatic vessel pacemaker potential and contractile activity J. Physiol., October 15, 2004; 560(2): 563 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kawabata, S. Kubo, T. Ishiki, N. Kawao, F. Sekiguchi, R. Kuroda, M. D. Hollenberg, T. Kanke, and N. Saito Proteinase-Activated Receptor-2-Mediated Relaxation in Mouse Tracheal and Bronchial Smooth Muscle: Signal Transduction Mechanisms and Distinct Agonist Sensitivity J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 402 - 410. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Darmoul, V. Gratio, H. Devaud, F. Peiretti, and M. Laburthe Activation of Proteinase-Activated Receptor 1 Promotes Human Colon Cancer Cell Proliferation Through Epidermal Growth Factor Receptor Transactivation Mol. Cancer Res., September 1, 2004; 2(9): 514 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Shpacovitch, G. Varga, A. Strey, M. Gunzer, F. Mooren, J. Buddenkotte, N. Vergnolle, C. P. Sommerhoff, S. Grabbe, V. Gerke, et al. Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices J. Leukoc. Biol., August 1, 2004; 76(2): 388 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Shi, B. Gangadharan, L. F. Brass, W. Ruf, and B. M. Mueller Protease-Activated Receptors (PAR1 and PAR2) Contribute to Tumor Cell Motility and Metastasis Mol. Cancer Res., July 1, 2004; 2(7): 395 - 402. [Abstract] [Full Text] [PDF] |
||||